-0.000453918330536292 -0.000155287849920328 -0.000274740042166747 -0.000185150897981891 -0.00030460309022831 -0.00260405779097065 0.00295017051800434 0.00342827791747038
Sign Up Today X
Thanks for submitting the form.
Stockreport

OpenAI takes on Google with new AI designed to speed drug discovery [Los Angeles Times (CA)]

Alphabet Inc. - Class C Capital Stock (GOOG)  More Company Research Source: Los Angeles Times
Last alphabet inc. - class c capital stock earnings: 4/28 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: abc.xyz/investor
for tech companies eager to prove AI can pave the way for more scientific breakthroughs. The ChatGPT maker said Thursday that the model, GPT-Rosalind, is intended for life sciences research, such as helping glean insights from large volumes of data and turning scientific studies into health-care applications for patients. The model will be available initially as a research preview to some of the company's business customers, OpenAI said. The initial users include drugmaker Amgen Inc., vaccine maker Moderna Inc. and the Allen Institute, a bioscience research nonprofit. OpenAI, Anthropic PBC and Alphabet Inc.'s Google have increasingly focused on scientific and health-care applications for AI, ranging from using the technology to help guide research on new drugs to having it review personal medical data. In 2024, two Google DeepMind scientists shared the Nobel Prize in chemistry for AlphaFold, an AI system that predicts protein structures. The technology is generally seen as nascent [Read more]
IMPACT SNAPSHOT EVENT TIME: GOOG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GOOG alerts
from News Quantified
GOOG
NEWS
GOOG
Earnings
GOOG
Analyst Actions
GOOG
SEC Filings
Stockreport

OpenAI takes on Google with new AI designed to speed drug discovery [Los Angeles Times (CA)]

Alphabet Inc. - Class C Capital Stock  (GOOG) 
More Company Research Source: Los Angeles Times
Last alphabet inc. - class c capital stock earnings: 4/28 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: abc.xyz/investor
for tech companies eager to prove AI can pave the way for more scientific breakthroughs. The ChatGPT maker said Thursday that the model, GPT-Rosalind, is intended for life sciences research, such as helping glean insights from large volumes of data and turning scientific studies into health-care applications for patients. The model will be available initially as a research preview to some of the company's business customers, OpenAI said. The initial users include drugmaker Amgen Inc., vaccine maker Moderna Inc. and the Allen Institute, a bioscience research nonprofit. OpenAI, Anthropic PBC and Alphabet Inc.'s Google have increasingly focused on scientific and health-care applications for AI, ranging from using the technology to help guide research on new drugs to having it review personal medical data. In 2024, two Google DeepMind scientists shared the Nobel Prize in chemistry for AlphaFold, an AI system that predicts protein structures. The technology is generally seen as nascent [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GOOG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS